Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis in Adults and Children Down to 2 Years of Age in the Pivotal Phase 3 ADORING Trials.
Silverberg JI, Eichenfield LF, Hebert AA, Simpson EL, Stein Gold L, Bissonnette R, Papp KA, Browning J, Kwong P, Korman NJ, Brown PM, Rubenstein DS, Piscitelli SC, Somerville MC, Tallman AM, Kircik L. Silverberg JI, et al. Among authors: piscitelli sc. J Am Acad Dermatol. 2024 May 20:S0190-9622(24)00755-2. doi: 10.1016/j.jaad.2024.05.023. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38777187 Free article.
Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials.
Jett J, McLaughlin M, Wilson T, Somerville M, DellaMaestra W, Rubenstein D, Piscitelli S. Jett J, et al. Among authors: piscitelli s. J Drugs Dermatol. 2022 Oct 1;21(10):1084-1090. doi: 10.36849/JDD.6627. J Drugs Dermatol. 2022. PMID: 36219046 Clinical Trial.
Hmga2 protein loss alters nuclear envelope and 3D chromatin structure.
Divisato G, Chiariello AM, Esposito A, Zoppoli P, Zambelli F, Elia MA, Pesole G, Incarnato D, Passaro F, Piscitelli S, Oliviero S, Nicodemi M, Parisi S, Russo T. Divisato G, et al. Among authors: piscitelli s. BMC Biol. 2022 Aug 2;20(1):171. doi: 10.1186/s12915-022-01375-3. BMC Biol. 2022. PMID: 35918713 Free PMC article.
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial.
Strober B, Stein Gold L, Bissonnette R, Armstrong AW, Kircik L, Tyring SK, Piscitelli SC, Brown PM, Rubenstein DS, Tallman AM, Lebwohl MG. Strober B, et al. Among authors: piscitelli sc. J Am Acad Dermatol. 2022 Oct;87(4):800-806. doi: 10.1016/j.jaad.2022.06.1171. Epub 2022 Jun 27. J Am Acad Dermatol. 2022. PMID: 35772599 Free article.
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J, Fromowitz J, Guenthner S, Piscitelli SC, Rubenstein DS, Brown PM, Tallman AM, Bissonnette R. Lebwohl MG, et al. Among authors: piscitelli sc. N Engl J Med. 2021 Dec 9;385(24):2219-2229. doi: 10.1056/NEJMoa2103629. N Engl J Med. 2021. PMID: 34879448 Clinical Trial.
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.
Jett JE, McLaughlin M, Lee MS, Parish LC, DuBois J, Raoof TJ, Tabolt G, Wilson T, Somerville MC, DellaMaestra W, Piscitelli SC. Jett JE, et al. Among authors: piscitelli sc. Am J Clin Dermatol. 2022 Jan;23(1):83-91. doi: 10.1007/s40257-021-00641-4. Epub 2021 Oct 28. Am J Clin Dermatol. 2022. PMID: 34713415 Free PMC article. Clinical Trial.
170 results